<PAGE> 1
DECHERT PRICE & RHOADS
1775 EYE STREET, N.W.
WASHINGTON, D.C. 20006
(202) 261-3300
March 3, 2000
VIA ELECTRONIC TRANSMISSION
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: The Coventry Group
File Nos. 33-44964 and 811-06526
Dear Sir or Madam:
Pursuant to Rule 497(j) under the Securities Act of 1933, we hereby
certify on behalf of The Coventry Group (the "Trust"), in connection with one of
the Trust's series: Willamette Technology Fund and Willamette Pharmaceutical &
Bio-Technology Fund (the "Fund"), that the form of Prospectus and Statement of
Additional Information that would have been filed under Rule 497(c) on behalf of
the fund does not differ from those contained in Post-Effective Amendment No. 66
which was filed on March 1, 2000. The text of Post-Effective Amendment No. 66
was filed electronically.
Please do not hesitate to contact the undersigned at (202) 261-3352 if you have
any questions regarding this filing.
Respectfully,
Olivia P. Adler
OPA/vp
